ArticleTherapeutic advances in neurological disorders2020

Long-term outcomes of monascin - a novel dual peroxisome proliferator-activated receptor γ/nuclear factor-erythroid 2 related factor-2 agonist in experimental intracerebral hemorrhage.

Pengcheng Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.